HEC PHARM (01558)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chen Hao | 08-Sep-23 | ED | |||
| Wong Wai Chiu | 25-Feb-22 | CoSec | |||
| Li Xuechen | 25-Sep-20 | INED | |||
| Xiang Ling | 05-Jun-20 | INED | |||
| Tang Jinlong | 06-Jun-19 | ChSup | |||
| Zhang Qiang | 25-Feb-19 | CFO | |||
| Peng Qiyun | 15-Oct-18 | CoSec | |||
| Li Shuang | 08-Jun-18 | ED, Dep GM | |||
| Wang Shengchao | 21-Jul-17 | Sup | |||
| Luo Zhonghua | 16-Jun-17 | Sup | |||
| Tang Xinfa | 04-May-15 | Ch | |||
| Jiang Juncai | 04-May-15 | ED, GM | |||
| Tang Jianxin | 04-May-15 | INED | |||
| Wang Danjin | 27-Feb-06 | ED, Dep GM | |||
| Chen Yangui | 04-May-15 | 14-Aug-23 | ED | Due to his decision to devote more time to his other business commitments | |
| Huang Eddy | 20-Feb-19 | 20-Sep-22 | Non-Executive Director | Due to his other business commitments | |
| Zhao Dayao | 11-Oct-19 | 20-Sep-22 | INED | Due to his other business commitments | |
| Ng Wing Shan | 24-Jul-15 | 25-Feb-22 | CoSec | Due to personal reasons | |
| Ng Wing Shan | 25-Feb-22 | J-CoSec, AuRep, Proc Agt | Due to personal reasons | ||
| Fu Hailiang | 04-May-15 | 05-Jun-20 | INED | ||
| Lee Chi Ming | 04-May-15 | 11-Oct-19 | INED | ||
| Huang Fangfang | 04-May-15 | 06-Jun-19 | ChSup | ||
| Zhu Qiaohong | 16-Jun-17 | 20-Feb-19 | Dep GM, ED | ||
| Pan Sanxiong | 15-Oct-18 | CoSec | |||
| Mo Kit | 04-May-15 | 08-Jun-18 | Non-Executive Director | ||
| Xue Lian | 04-May-15 | 21-Jul-17 | Sup | ||
| Lin Jian | 04-May-15 | 16-Jun-17 | Sup | ||
| Zhu Yingwei | 08-Aug-01 | 09-May-17 | Non-Executive Director |